Norris Medicines Statistics

Total Valuation

BOM:524414 has a market cap or net worth of INR 130.01 million. The enterprise value is 344.08 million.

Market Cap	130.01M
Enterprise Value	344.08M

Important Dates

The last earnings date was Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:524414 has 10.00 million shares outstanding. The number of shares has increased by 1.99% in one year.

Current Share Class	10.00M
Shares Outstanding	10.00M
Shares Change (YoY)	+1.99%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	24.00%
Owned by Institutions (%)	1.50%
Float	2.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.38
PB Ratio	-0.82
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-61.48
EV / Sales	3.64
EV / EBITDA	72.64
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	45.33
Debt / FCF	n/a
Interest Coverage	-0.08

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-0.68%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	0.86%
Revenue Per Employee	2.86M
Profits Per Employee	-169,603
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BOM:524414 has paid 594,256 in taxes.

Income Tax	594,256
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.20% in the last 52 weeks. The beta is -0.88, so BOM:524414's price volatility has been lower than the market average.

Beta (5Y)	-0.88
52-Week Price Change	-24.20%
50-Day Moving Average	14.53
200-Day Moving Average	16.40
Relative Strength Index (RSI)	49.53
Average Volume (20 Days)	1,310

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524414 had revenue of INR 94.44 million and -5.60 million in losses. Loss per share was -0.56.

Revenue	94.44M
Gross Profit	37.58M
Operating Income	-374,497
Pretax Income	-5.00M
Net Income	-5.60M
EBITDA	4.74M
EBIT	-374,497
Loss Per Share	-0.56

Full Income Statement

Balance Sheet

The company has 646,000 in cash and 214.72 million in debt, with a net cash position of -214.07 million or -21.41 per share.

Cash & Cash Equivalents	646,000
Total Debt	214.72M
Net Cash	-214.07M
Net Cash Per Share	-21.41
Equity (Book Value)	-158.96M
Book Value Per Share	-15.94
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 39.79%, with operating and profit margins of -0.40% and -5.93%.

Gross Margin	39.79%
Operating Margin	-0.40%
Pretax Margin	-5.30%
Profit Margin	-5.93%
EBITDA Margin	5.02%
EBIT Margin	-0.40%
FCF Margin	n/a

Dividends & Yields

BOM:524414 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.99%
Shareholder Yield	-1.99%
Earnings Yield	-4.31%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 22, 2013. It was a reverse split with a ratio of 0.3000003.

Last Split Date	Aug 22, 2013
Split Type	Reverse
Split Ratio	0.3000003

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a